Skip to main content

Table 2 Prevalence of very good/good self-rated health among all PLHIV, PLHIV on antiretroviral treatment and PLHIV on antiretroviral treatment virally suppressed

From: Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

  All PLHIV Very good/good self-rated health among all PLHIV On ART Very good/good self-rated health among PLHIV on ART On ART virally suppressed Very good/good self-rated health among PLHIV on ART virally suppressed
n n % (95% CI) n n % (95% CI) n n % (95% CI)
Gender
 Male 591 404 68.4 (64.4–72.1) 571 398 69.7 (65.8–73.4) 516 377 73.1 (69.0–76.8)
 Female 195 127 65.1 (58.0–71.8) 193 126 65.3 (58.1–72.0) 177 120 67.8 (60.4–74.6)
 Transgender 12 8 66.7 (34.9–90.0) 11 7 63.6 (30.8–89.1) 8 6 75.0 (34.9–96.8)
 Unknown 2 1 50.0 (1.3–98.7) 1 0 0 1 0 0
Age group (years)
  < 35 111 86 77.5 (68.6–84.9) 103 82 79.6 (70.5–86.9) 91 73 80.2 (70.6–87.8)
 35–50 282 197 69.9 (64.1–75.2) 274 194 70.8 (65.0–76.1) 240 182 75.8 (69.9–81.1)
 51–60 299 188 62.9 (57.1–68.4) 295 187 63.4 (57.6–68.9) 274 182 66.4 (60.5–72.0)
  > 60 95 60 63.2 (52.6–72.8) 92 60 65.2 (54.6–74.9) 87 59 67.8 (56.9–77.4)
 Unknown 13 9 69.2 (38.6–90.9) 12 8 66.7 (34.9–90.1) 10 7 70.0 (34.8–93.3)
Educational level
 Illiteracy/Primary education 327 189 57.8 (52.2–63.2) 319 188 58.9 (53.3–64.4) 285 176 61.8 (55.8–67.4)
 Secondary education 258 183 70.9 (65.0–76.4) 252 180 71.4 (65.4–76.9) 229 172 75.1 (69.0–80.6)
 University education 180 150 83.3 (77.1–88.5) 171 146 85.4 (79.2–90.3) 159 139 87.4 (81.2–92.1)
 Unknown 35 18 51.4 (34.0–68.6) 34 17 50.0 (32.4–67.6) 29 16 55.2 (35.7–73.6)
Country of birth
 Spain 631 412 65.3 (61.4–69.0) 613 406 66.2 (62.3–70.0) 566 390 68.9 (64.9–72.7)
 Other 164 123 75.0 (67.7–81.4) 158 120 76.0 (68.5–82.4) 132 109 82.6 (75.0–88.6)
 Unknown 5 5 100.0 (−) 5 5 100 (48.0–100) 4 4 100 (39.8–100)
Residence
 Living with family 478 330 69.0 (63.4–71.9) 467 326 69.8 (65.4–73.9) 428 309 72.2 (67.7–76.4)
 Living alone 216 142 65.7 (59.0–72.0) 208 139 66.8 (60.0–73.2) 188 136 72.3 (65.4–78.6)
 Closed institutions/Prison/ Homeless 31 11 35.5 (19.2–54.6) 31 11 35.5 (19.2–54.6) 25 9 36.0 (18.0–57.5)
 Other 70 56 80.0 (68.7–88.6) 65 54 83.1 (71.7–91.2) 59 48 81.4 (69.1–90.3)
 Unknown 5 1 20.0 (0.5–71.6) 5 1 20.0 (0.5–71.6) 2 1 50.0 (1.2–98.7)
Employment status
 Employed 430 353 82.1 (78.1–85.6) 421 348 82.7 (78.7–86.2) 389 333 85.6 (81.7–88.9)
 Unemployed 139 65 46.8 (38.3–55.4) 126 61 48.4 (39.4–57.5) 105 54 51.4 (41.5–61.3)
 Retired/disabled 184 86 46.7 (39.4–54.2) 182 86 47.2 (39.8–54.8) 167 82 49.1 (41.3–56.9)
 Student 23 20 87.0 (66.4–97.2) 23 20 87.0 (66.4–97.2) 22 19 86.4 (65.1–97.1)
 Other/ unknown 24 16 66.7 (44.7–84.4) 24 16 66.7 (44.7–84.4) 19 15 78.9 (54.4–93.9)
Mode of transmission
 Heterosexual 246 171 69.5 (63.3–75.2) 240 168 70.0 (63.8–75.7) 216 161 74.5 (68.2–80.2)
 MSM 293 228 77.8 (72.6–82.4) 282 223 79.1 (73.9–83.7) 260 210 80.8 (75.4–85.4)
 PWID 195 101 51.8 (44.5–59.0) 192 101 52.6 (45.3–59.8) 169 95 56.2 (48.4–63.8)
 Other/ unknown 66 40 60.6 (47.8–72.4) 62 39 62.9 (49.7–74.8) 57 37 64.9 (51.1–77.1)
HIV infection stage
 Asymptomatic 386 299 77.5 (73.0–81.5) 378 296 78.3 (73.8–82.4) 353 280 79.3 (74.7–83.4)
 Symptomatic non AIDS 126 80 63.5 (54.4–71.9) 122 77 63.1 (53.9–71.7) 111 72 64.9 (55.2–73.7)
 AIDS 267 144 53.9 (47.8–60.0) 257 143 55.6 (49.3–61.8) 224 141 63.0 (56.3–69.3)
 Unknown 21 17 80.9 (58.1–94.6) 19 15 78.9 (54.4–93.9) 14 10 71.4 (41.9–91.6)
Viral load < 200 copies/ml (last determination)
 Yes 704 503 71.4 (68.0–74.8) 702 503 71.6 (68.2–75.0)
 No 71 24 33.8 (23.0–46.0) 56 17 30.4 (18.8–44.0)
 Unknown 25 13 52.0 (31.3–72.2) 18 11 61.1 (35.7–82.7)
CD4 count (last determination)
  < 200 67 14 20.9 (11.9–32.6) 61 12 19.7 (10.6–31.8) 36 10 27.8 (14.2–45.2)
 200–349 92 48 52.2 (41.5–62.7) 89 47 52.8 (51.9–63.5) 76 91 59.2 (47.3–70.4)
 350–499 116 71 61.2 (51.7–70.1) 112 68 60.7 (51.0–69.8) 99 60 60.6 (50.2–70.3)
  > =500 499 391 78.4 (74.5–81.9) 496 391 78.8 (75.0–82.3) 483 381 78.9 (75.0–82.4)
 Unknown 26 16 61.5 (40.6–79.8) 18 13 72.2 (46.5–90.3) 8 7 87.5 (47.3–99.7)
Comorbidities
 Yes 88 29 33.0 (23.3–43.8) 87 29 33.3 (23.6–44.3) 72 27 37.5 (26.4–49.7)
 No/ Unknown 712 511 71.8 (66.3–75.0) 689 502 72.9 (69.3–76.1) 630 476 75.6 (72.0–78.9)
Antiretroviral treatment
 Yes 776 531 68.4 (65.0–71.7)
 No 18 8 44.4 (21.5–69.2)
 Unknown 6 1 16.7 (0.4–64.1)
Adherence
 Optimal 653 471 72.1 (68.5–75.5) 653 471 72.1 (68.5–75.5) 611 451 73.8 (70.1–77.3)
 Suboptimal 68 36 52.9 (40.4–65.1) 68 36 52.9 (40.4–65.2) 56 31 55.4 (41.5–68.7)
 Very bad 25 3 12.0 (2.5–31.2) 25 3 12.0 (2.5–31.2) 8 1 12.5 (3.2–52.7)
 Unknown 30 21 70.0 (50.6–85.2) 30 21 70.0 (50.6–85.3) 27 20 74.1 (53.7–88.9)
 No/unknown ART 24 9 37.5 (18.8–59.4)
Years since HIV diagnosis
  < 2 73 42 57.5 (45.4–69.0) 59 34 57.6 (44.1–70.4) 38 27 71.1 (54.1–84.6)
 2–5 111 86 77.5 (68.6–84.8) 109 86 78.9 (70.0–86.1) 99 81 81.8 (72.3–88.6)
 6–10 121 93 76.9 (68.3–84.0) 120 93 77.5 (69.0–84.6) 110 89 80.9 (72.3–87.8)
 11–15 111 77 69.4 (59.9–77.8) 110 77 70.0 (60.5–78.4) 104 75 72.1 (62.5–80.5)
  > 15 374 233 62.3 (57.2–67.2) 369 233 63.1 (58.0–68.1) 345 225 65.2 (60.0–70.2)
 Unknown 10 9 90.0 (55.5–99.7) 9 8 88.9 (51.7–99.7) 6 6 100 (54.1–100)
Total 800 540 67.5 (64.1–70.7) 776 531 68.4 (65.0–71.7) 702 503 71.7 (68.2–75.0)
  1. 95% CI Confidence interval 95%, PLHIV People living with HIV, ART antiretroviral treatment, MSM Men who have sex with men, PWID People who injected drugs